Feline hypertrophic cardiomyopathy: an update

Area of Science:

• Veterinary Cardiology
• Feline Medicine

Background:

• Hypertrophic cardiomyopathy (HCM) is morphologically defined by ventricular hypertrophy in cats.
• It is the most prevalent cardiac condition diagnosed in feline patients.
• Despite recent progress, the etiology and management of feline HCM require further investigation.

Purpose of the Study:

• To provide a comprehensive review of feline hypertrophic cardiomyopathy.
• To update knowledge on the disease's cause, epidemiology, pathophysiology, and therapeutic strategies.
• To emphasize recent findings and advancements in the field.

Main Methods:

• Literature review and synthesis of current research.
• Analysis of recent studies on feline hypertrophic cardiomyopathy.
• Compilation of updated information since the last review in this series.

Main Results:

• Significant advancements have been made in understanding the underlying causes and clinical manifestations of feline HCM.
• Epidemiological data and pathophysiological mechanisms continue to be refined.
• Current therapeutic approaches and their efficacy are discussed, with emphasis on novel findings.

Conclusions:

• Feline hypertrophic cardiomyopathy remains a complex disease with ongoing research.
• A thorough understanding of recent advances is crucial for effective diagnosis and management.
• Further research is essential to fully elucidate the complexities of feline HCM and improve patient outcomes.